Regulatory T Cells Are Protective in Systemic Inflammation Response Syndrome Induced by Zymosan in Mice

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Jia, Wenyuan ^a   Cao, Li ^a   Yang, Shuangwen ^a   Dong, Hailong ^a   Zhang, Yun ^b   Wei, Haidong ^a   Jing, Wei ^a   Hou, Lichao ^a   Wang, Chen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNE DYSREGULATION; IMMUNOMODULATION; LUNG INJURY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WESTERN BLOTTING;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; LUNG; LYMPHOCYTE DEPLETION; MALE; MICE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES, REGULATORY; ZYMOSAN;

EID: 84877627305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064397     Document Type: Article

References (27)

1. Seely AJ, Christou NV, (2000) Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28: 2193-2200.
2. Volman TJ, Goris RJ, van der Meer JW, Hendriks T, (2004) Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome. Ann Surg 240: 142-150.
3. Sharma R, Sharma PR, Kim YC, Leitinger N, Lee JK, et al. (2011) IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: implication to multiorgan inflammation and control of skin and lung inflammation. J Immunol 186: 1268-1278.
4. O'Garra A, Vieira P, (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10: 801-805.
5. Wing K, Sakaguchi S, (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11: 7-13.
6. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27.
7. O'Connor RA, Anderton SM, (2008) Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol 193: 1-11.
8. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, et al. (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15: 192-199.
9. Wisnoski N, Chung CS, Chen Y, Huang X, Ayala A, (2007) The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27: 251-257.
10. Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, et al. (2006) Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 177: 7943-7949.
11. Heuer JG, Zhang T, Zhao J, Ding C, Cramer M, et al. (2005) Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 174: 7141-7146.
12. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, et al. (2009) Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35: 678-686.
13. Nascimento DC, Alves-Filho JC, Sonego F, Fukada SY, Pereira MS, et al. (2010) Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis. Crit Care Med 38: 1718-1725.
14. R. Jan A. Goris M, Willem K. F. Boekholtz M, Ignas P. T. Van Bebber M, Johan K. S. Nuytinck M, Paul H. M. Schillings M (1986) Multiple-Organ Failure and Sepsis Without Bacteria. Arch Surg.
15. Volman TJ, Hendriks T, Goris RJ, (2005) Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23: 291-297.
16. Jansen MJ, Hendriks T, Verhofstad AA, Lange W, Geeraedts LJ, et al. (1997) Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome. Shock 8: 261-267.
17. Baker CC, Chaudry IH, Gaines HO, Baue AE, (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94: 331-335.
18. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LR, et al. (2005) Cecal ligation and puncture. Shock 24Suppl 1: 52-57.
19. Ferrer TJ, Webb JW, Wallace BH, Bridges CD, Palmer HE, et al. (1998) Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS). J Surg Res 77: 157-164.
20. Tenorio EP, Olguin JE, Fernandez J, Vieyra P, Saavedra R, (2010) Reduction of Foxp3+ cells by depletion with the PC61 mAb induces mortality in resistant BALB/c mice infected with Toxoplasma gondii. J Biomed Biotechnol 2010: 786078.
21. McNeill A, Spittle E, Backstrom BT, (2007) Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand J Immunol 65: 63-69.
22. Taylor JJ, Mohrs M, Pearce EJ, (2006) Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 176: 5839-5847.
23. Couper KN, Blount DG, de Souza JB, Suffia I, Belkaid Y, et al. (2007) Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol 178: 4136-4146.
24. Couper KN, Lanthier PA, Perona-Wright G, Kummer LW, Chen W, et al. (2009) Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection. J Immunol 182: 3985-3994.
25. Bosmann M, Russkamp NF, Patel VR, Zetoune FS, Sarma JV, et al. (2011) The outcome of polymicrobial sepsis is independent of T and B cells. Shock 36: 396-401.
26. Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, et al. (2008) Adverse functions of IL-17A in experimental sepsis. FASEB J 22: 2198-2205.
27. Petermann F, Rothhammer V, Claussen MC, Haas JD, Blanco LR, et al. (2010) gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33: 351-363.